Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Carcinoembryonic antigen in serum of unselected breast-cancer patients and of non-hospitalized controls

Abstract

A series of consecutive unselected patients with primary breast carcinoma and their age-matched controls were studied for serum CEA in relation to clinical findings. Raised CEA was found in a similar frequency in patients with primary breast cancer (pre- and postoperative) and in the control women: 16%, 11% and 11%, respectively, exceeded the selected upper limit of the reference range (13 ng/ml) with a double-antibody radioimmunoassay. In the breast-cancer patients, however, 48% of the raised CEA levels exceeded 16 ng/ml, compared with only 20% in the controls. Significant correlations (r approximately 0.3) were found between CEA levels and tumour size, TNM classification and a combined clinical and histopathological classification. A high frequency of raised CEA values in the advanced breast-cancer patients was the essential contribution to these positive correlations. A correlation coefficient of 0.6 was found between pre- and postoperative CEA values. The frequency of smoking and/or chronic disease was unexpectedly high in patients as well as in controls with high CEA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rimsten, Å., Adami, H., Wahren, B. et al. Carcinoembryonic antigen in serum of unselected breast-cancer patients and of non-hospitalized controls. Br J Cancer 39, 109–115 (1979). https://doi.org/10.1038/bjc.1979.20

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1979.20

This article is cited by

Search

Quick links